{"entity":{"type":"insider","cik":"0001613377","url":"/insider/0001613377","json_url":"/insider/0001613377.json","name":"PASCALE ADAM","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2017-02-21","last":"2018-07-23","span_basis":"filed_date"},"name_variants":[{"name":"PASCALE ADAM","source":"filing","n_filings":1,"first_seen":"2018-07-23","last_seen":"2018-07-23"},{"name":"Pascale Adam","source":"filing","n_filings":2,"first_seen":"2017-02-21","last_seen":"2017-05-02"}],"transactions":[{"id":6299870,"accession":"0001613377-18-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001613377-18-000017","line_url":"/filing/0001613377-18-000017#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001613377","owner_name":"PASCALE ADAM","owner_url":"/insider/0001613377","role":"Officer (CFO)","officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32259.0,"shares_display":"32,259","price_per_share":0.31,"price_display":"0.31","price_state":"stated","total_value":10000.29,"total_display":"10,000.29","shares_owned_after":59648.0,"shares_owned_after_display":"59,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-23","filed_date":"2018-07-23","scope":"insider"},{"id":4597868,"accession":"0001613377-17-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001613377-17-000005","line_url":"/filing/0001613377-17-000005#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001613377","owner_name":"Pascale Adam","owner_url":"/insider/0001613377","role":"Officer (CFO)","officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15873.0,"shares_display":"15,873","price_per_share":0.63,"price_display":"0.63","price_state":"stated","total_value":9999.99,"total_display":"9,999.99","shares_owned_after":27389.0,"shares_owned_after_display":"27,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-02","filed_date":"2017-05-02","scope":"insider"},{"id":4421009,"accession":"0001613377-17-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001613377-17-000001","line_url":"/filing/0001613377-17-000001#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001613377","owner_name":"Pascale Adam","owner_url":"/insider/0001613377","role":"Officer (CFO)","officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6981.0,"shares_display":"6,981","price_per_share":0.46,"price_display":"0.46","price_state":"stated","total_value":3211.26,"total_display":"3,211.26","shares_owned_after":11516.0,"shares_owned_after_display":"11,516","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-02-21","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000946644","name":"HEMISPHERX BIOPHARMA INC","url":"/issuer/0000946644","role":"Officer (CFO)","n_filings":3,"first_seen":"2017-02-21","last_seen":"2018-07-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001613377","retrieved_at":"2026-08-21T16:09:36+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}